Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Equity (2021 - 2025)

Historic Return on Equity for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to 0.18%.

  • Krystal Biotech's Return on Equity rose 1200.0% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.1% for FY2024, which is 900.0% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Return on Equity is 0.18%, which was up 1200.0% from 0.14% recorded in Q2 2025.
  • Krystal Biotech's Return on Equity's 5-year high stood at 0.18% during Q3 2025, with a 5-year trough of 0.27% in Q1 2023.
  • In the last 5 years, Krystal Biotech's Return on Equity had a median value of 0.01% in 2023 and averaged 0.05%.
  • In the last 5 years, Krystal Biotech's Return on Equity crashed by -1200bps in 2022 and then surged by 3800bps in 2024.
  • Over the past 5 years, Krystal Biotech's Return on Equity (Quarter) stood at 0.14% in 2021, then tumbled by -90bps to 0.26% in 2022, then skyrocketed by 105bps to 0.01% in 2023, then soared by 583bps to 0.1% in 2024, then surged by 88bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.14% for Q2 2025, and 0.13% during Q1 2025.